Last Friday, Exact Sciences Chairman and CEO Kevin Conroy appeared on CNBC's Mad Money to discuss Cologuard, Exact Sciences' FDA-approved noninvasive stool DNA screening test for colorectal cancer (available by prescription only).

You can watch a clip of Conroy's appearance below. For other investor content, view our investor site or investor blog.